Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -57.53% | -58.19% | 77.70% | 30.66% | -22.62% |
| Total Other Revenue | 320.35% | -- | -- | -- | -- |
| Total Revenue | -56.68% | -57.06% | 78.13% | 30.98% | -22.44% |
| Cost of Revenue | -14.32% | 8.64% | 44.08% | 35.29% | -5.37% |
| Gross Profit | -72.63% | -81.81% | 89.18% | 29.68% | -27.38% |
| SG&A Expenses | -26.89% | -10.10% | 35.63% | 10.35% | -3.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.22% | -0.70% | 33.29% | 18.14% | -7.82% |
| Operating Income | -381.81% | -241.40% | 589.01% | 255.09% | -221.56% |
| Income Before Tax | -329.95% | -165.57% | 518.62% | 263.39% | 18.61% |
| Income Tax Expenses | 1,958.60% | -120.71% | 664.61% | 93.75% | -197.56% |
| Earnings from Continuing Operations | -924.99% | -182.10% | 469.53% | 74.90% | 44.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -924.99% | -182.10% | 469.53% | 74.90% | 44.89% |
| EBIT | -381.81% | -241.40% | 589.01% | 255.09% | -221.56% |
| EBITDA | -669.02% | -302.12% | 413.19% | 153.95% | -147.72% |
| EPS Basic | -702.49% | -156.96% | 510.82% | 23.12% | 25.19% |
| Normalized Basic EPS | -408.85% | -252.16% | 603.24% | 304.73% | -227.76% |
| EPS Diluted | -702.49% | -156.96% | 555.36% | 22.22% | 25.19% |
| Normalized Diluted EPS | -408.85% | -252.16% | 587.63% | 296.69% | -227.76% |
| Average Basic Shares Outstanding | 1.44% | 1.19% | -2.13% | -4.29% | -4.31% |
| Average Diluted Shares Outstanding | 1.44% | 1.19% | 0.03% | -2.30% | -4.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |